Eternygen GmbH
PrivateLast Round
Series A
Extension
Oct 26, 2020
Total Funding Raised
$14.2M
Company Overview
Eternygen GmbH operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Series A Extension round in October 2020.
Eternygen GmbH is a biotechnology company that focuses on the research and development of innovative drugs for dietary-related metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eternygen GmbH Comparables
Compare Eternygen GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galmed Pharmaceuticals | 76% | |
| Inventiva S.A. | 70% | |
| HepaRegeniX GmbH | 69% |
For institutional investors. Book with your work email.
Eternygen GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 26, 2020 | ||||
| Series A | Jan 9, 2017 |
For institutional investors. Book with your work email.
Eternygen GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Series A Extension, Series A |
| IBB Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2020
$6M round led by Evotec
- Jan 9, 2017
$8.3M round led by Epidarex Capital.
For institutional investors. Book with your work email.
Eternygen GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eternygen GmbH's valuation, stock price, and market status.
Is Eternygen GmbH a public or private company?
Eternygen GmbH is a private company.
What is the current stock price of Eternygen GmbH?
Eternygen GmbH is a private company, so its shares have no public market price. Caplight tracks Eternygen GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eternygen GmbH worth (valuation)?
Valuation information for Eternygen GmbH is not publicly available.
Can I buy Eternygen GmbH stock?
Eternygen GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eternygen GmbH's last funding round?
Eternygen GmbH's most recent funding round was Series A Extension on October 26, 2020.
Who are the main investors in Eternygen GmbH?
Key investors in Eternygen GmbH include Epidarex Capital.
Will Eternygen GmbH IPO soon?
No public IPO plans have been announced for Eternygen GmbH.
How can I track Eternygen GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Eternygen GmbH's shares on secondary markets.